IntoMed

MEYTEL S.L.

Mayelana nalolu hlelo lokusebenza

I-IntoMed ifuna ukuba yithuluzi lokusekela iziguli nezihlobo ezithintekile ngenxa yokungabekezelelani kwe-Fructose (HFI), i-Fructose Malabsorption, Ukungabekezelelani kwe-Lactose, Isifo sikashukela, Isifo seCeliac, i-Galactosemia kanye ne-Phenylketonuria, kanye nabasebenzi bezokunakekelwa kwempilo, ukwazisa ngokubekezelelwa kwezidakamizwa ngokusho kwabo. abasizayo.

Abasizi ku-nomenclature kadokotela ye-Spanish Agency for Medicines and Health Products (AEMPS: https://cima.aemps.es/cima/publico/nomenclator.html) bahlelwe ngokuya ngama-pathologies angu-7 (okuzalwa noma atholiwe) futhi yokuphatha, kucatshangelwa ulwazi lwe-CIRCULAR Nº 1/2018 (Isibuyekezo solwazi ngabasizi olwazini lwezidakamizwa, I-Spanish Agency of Medicines and Health Products) kanye nemithombo yebhayibheli yokuvelela okwaziwayo.

Ekungabekezelelani kwamathumbu emathunjini (ukungabekezelelani kwe-lactose kanye ne-fructose malabsorption) kuphela izithasiselo zomlomo eziye zaphikiswa/azinganconywa. Endabeni ye-fructose ne-sorbitol ngomlomo nangabazali (hhayi ngomjovo), ngokomthetho wamanje, isexwayiso sizovela kuphela eshidini ledatha yeziguli ezine-HFI esimweni esingaphezu kuka-5 mg/kg/ngosuku (CIRCULAR Nº 1/ 2018 AEMPS).

Indlela yokusebenza iklanywe futhi yabuyekezwa ngosokhemisi abavela ku-Pharmacy Service ye-Infanta Leonor University Hospital.